Clinical Trial Update: Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for OST-122 in moderate to severe ulcerative colitis completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• OST-122

Snippet

Sponsor: Oncostellae S.L | Conditions: Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe | Phase 1, Phase 2 | Status: COMPLETED